Skip to main content

Table 2 Continuous variable of patients with or without UFUR maintenance for ypstage III rectal cancer

From: Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study

Variable with UFUR maintenance
Median (Range)
without UFUR maintenance
Median (Range)
P value
Age 64.7 (35–86) 68.0 (13–83) 0.185
BMI 24.1 (16.3–31.9) 24.2 (13.2–34.0) 0.675
CEA, ng/mL 4.8 (0.5–116.5) 4.0 (0.4–53.13) 0.212
ELN 14 (4–43) 21 (3–51) 0.029
LNR 0.21 (0.03–0.92) 0.20 (0.02–0.84) 0.782
Tumorlocation, cm 6.63 (1–12) 7.42 (3–12) 0.254
Follow-up (month) 64.0 (19.0–124.0) 73.1 (15.4–148.3) 0.207
  1. UFUR tegafur-uracil, BMI body mass index, CEA carcinoembryonic antigen, ELN total examined nodes number, LNR the ratio of metastatic lymph nodes to the total examined nodes number